Anita Shinderman

Title: Anita Shinderman: Innovator in Rapid Antimicrobial Susceptibility Testing

Introduction

Anita Shinderman is a prominent inventor based in Ashdod, IL. She has made significant contributions to the field of medical diagnostics, particularly in the area of antimicrobial susceptibility testing. Her innovative approach has the potential to revolutionize how bacterial infections are treated.

Latest Patents

Anita holds a patent for a groundbreaking method titled "Rapid antimicrobial susceptibility testing based on a unique spectral intensity ratio analysis via single fluorescence membrane dye staining and flow cytometry." This patent describes a technique that utilizes single dye fluorescent staining combined with differences in both intensity and spectral emission. This method allows for the determination of the minimum concentration of an antibiotic needed to inactivate bacteria, known as the Minimum Inhibitory Concentration (MIC). This rapid Antibiotic Susceptibility Testing (AST) provides clinicians with a quick and effective means to determine suitable treatment regimens for patients suffering from bacterial infections, which can lead to sepsis.

Career Highlights

Anita Shinderman is currently associated with Pocared Diagnostics Ltd., where she continues to develop innovative solutions in the field of diagnostics. Her work is instrumental in enhancing the speed and accuracy of bacterial infection treatments.

Collaborations

Anita collaborates with notable colleagues, including Gal Ingber and Moshe Ben-David, who contribute to her research and development efforts.

Conclusion

Anita Shinderman's contributions to antimicrobial susceptibility testing exemplify the impact of innovation in healthcare. Her work not only advances medical diagnostics but also improves patient outcomes in the fight against bacterial infections.